PPARγ suppressed Wnt/β-catenin signaling pathway and its downstream effector SOX9 expression in gastric cancer cells

Pravastatin prevents steroid-induced osteonecrosis in rats by suppressing PPARγ expression and activating Wnt signaling pathway

(2014) Yini Jiang et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

(2014) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Oxaliplatin Neurotoxicity Involves Peroxisome Alterations. PPARγ Agonism as Preventive Pharmacological Approach

(2014) Matteo Zanardelli et al.   PLoS One

SOX9 Is Highly Expressed in Nonampullary Duodenal Adenoma and Adenocarcinoma in Humans

(2013) Hirotsugu Sakamoto et al.   Gut and Liver

Study of risk factors for gastric cancer by populational databases analysis

(2013) Fangio Ferrari   WORLD JOURNAL OF GASTROENTEROLOGY

Enhancer of zeste homolog 2 activates wnt signaling through downregulating CXXC finger protein 4

(2013) H Lu et al.   Cell Death & Disease

Wnt signaling pathways in urological cancers: past decades and still growing

(2012) Shahana Majid et al.   Molecular Cancer

SOX9 expression and its methylation status in gastric cancer

(2012) Minhua Sun et al.   VIRCHOWS ARCHIV

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

Progression from Chronic Atrophic Gastritis to Gastric Cancer; Tangle, Toggle, Tackle with Korea Red Ginseng

(2010) Yoon Jae Kim et al.   JOURNAL OF CLINICAL BIOCHEMISTRY AND NUTRITION

Epidemiology ofHelicobacter pyloriinfection and gastric cancer in Asia

(2009) Kwong Ming Fock et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

PPAR  is involved in mesalazine-mediated induction of apoptosis and inhibition of cell growth in colon cancer cells

(2008) M. Schwab et al.   CARCINOGENESIS

Peroxisome Proliferator-Activated Receptor γ (PPARγ) Suppresses Colonic Epithelial Cell Turnover and Colon Carcinogenesis Through Inhibition of the β-Catenin / T Cell Factor (TCF) Pathway

(2008) Toshio Fujisawa et al.   JOURNAL OF PHARMACOLOGICAL SCIENCES

A small-molecule inhibitor of Tcf/ -catenin signaling down-regulates PPAR  and PPAR  activities

(2008) S. Handeli et al.   MOLECULAR CANCER THERAPEUTICS